Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform. (2022)
Attributed to:
Novel methods in data science to quantify viral and environmental triggers of chronic disease exacerbations
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmj-2022-071932
PubMed Identifier: 36384890
Publication URI: http://europepmc.org/abstract/MED/36384890
Type: Journal Article/Review
Volume: 379
Parent Publication: BMJ (Clinical research ed.)
ISSN: 0959-8138